Navigation Links
New Medicine For Parkinson’s disease,

A new drug called Azilect manufactured by Teva Pharmaceutical Industries Ltd. is said to help people with //disabilities from Parkinson’s disease.

According to the latest investigations, Azilect also called Rasagiline can improve the physical abilities of patients suffering from Parkinson’s. Rasagiline is a new drug and when taken along with the treatment of Levodopa, can cause some irreversible changes in the body that will increase the extent of motor activities for the patient with Parkinson’s.

Parkinson’s disease is a disorder of the nervous system. Some of its symptoms are muscle tremors, muscle rigidity, decreased mobility, stooped posture, slow voluntary movements, and a mask-like facial expression. One of the treatments of this disorder is the drug Levodopa. When given in conjunction with this, the new drug Rasagiline is said to lessen the off hours (hours during which any drug has least effect) of Levodopa by about half-an hour daily. This is good news for patients who have been suffering from this disorder for very long and find their body resisting the effect of the drug Levodopa.

Azilect is waiting for approval by Food and Drug administration of USA before it can be marketed.

Once available in the market, the drug may bring relief to millions of people suffering from the dreaded Parkinson’s disease.

Link: http://www.thelancet.com/jounal/
'"/>




Page: 1

Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Prince Charles lends support to Alternative Medicine
3. Healthy Medicine Or Harmful Intoxicant?
4. Medicines on the move
5. A surge in Lifestyle Medicine
6. Does Your Prescription Have An Inappropriate Medicine?
7. The Use Of Alternative Medicine On The Rise
8. Advent of New, More Effective and Personalized Medicines
9. Combing Hair More Effective Than OTC Medicine For Head Lice
10. Heart Patients Use Alternative Medicine
11. Nobel Prize for Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Medicine For Parkinson disease

(Date:10/7/2008)...GTON, Oct. 7 /PRNewswire-USNewswire/ -- Kristi Yam...er of Dancing With the Stars, has been,named chair...stmas Seals,Campaign in an effort to help raise fu...revent lung disease and promote lung health., The...on began in 1907,to conquer Tuberculosis. Today, t...
(Date:10/7/2008)...n ultrasound similar to more expensive whole-leg c...ESDAY, Oct. 7 (HealthDay News) -- An older, simple...d deep vein thrombosis, or DVT -- is as effective .... , European researchers found that 2-point ult...ssion or duplex ultrasound -- was as good at detec...
(Date:10/7/2008)...ILLE, Fla. Based on results of a landmark study, ...future in which virtual biopsies will eliminate th...us or will not morph into the disease. , Curren...ring colonoscopies end up being harmless, but they...reases time, expense and the potential for complic...
(Date:10/7/2008)... introduces Color Me Healthy(TM)/Salud Primero to ...urriculum, BENSENVILLE, Ill., Oct. 7 /PRNewswire/...an expansive campaign to bring a comprehensive die...t and Early Head Start,classrooms in an effort to ...ty and diabetes in minority children. Lifelink als...
Breaking Medicine News(10 mins):Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3Health News:Mayo Clinic estimates new, tiny, super-sensitive probe could cut colon polyp removal in half 2Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 2Health News:DuPage's Only Provider of Head Start Takes Aim at Childhood Obesity in Minorities 3
...eading player in the Indian drug industry, has rec...Authority (FDA) for three// of its abbreviated new...d will be launching this product in the US through...potex, the Chennai-based company said in a release...
...eople suffering from osteoporosis are not told abo...cording to the research by the University of Weste...alians being affected by osteoporosis, the problem...ly. Dr Charles Inderjeeth from the School of Popu...
...rimination against HIV/AIDS victims will be tabled...or approval.// In the light of the XVI Internatio...i Ramadoss said, "it took a little time, because w...d elaborate discussions with the stakeholders. Hop...
...ed yesterday that a Walkers crisps advertising cam...ntent.// According to the industry watchdog a pro...salt in its crisps to "7% of your guideline daily ...act that the reduction did not apply to all Walker...
Other Medicine News:Health News:Negligence in Osteoporosis treatment 2Health News:Legislation to Prevent Discrimination against HIV/AIDS Victims 2
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A...examining embryonic stem cell self-renewal,report...lastim (recombinant,human serum albumin) was an ef...cell culture., The article entitled, "The ground ...sed that researchers used Cellastim as a recombina...
(Date:10/7/2008)... CAMBRIDGE, Mass., Oct. 7 /- Tali... data on several of the Company,s pipeline,candida...ement Workshop in,Basel, Switzerland. The data hig...l models of complement-mediated diseases., "These...vitro studies,presented at the conference, reveal ...
(Date:10/7/2008)... Several abstracts highlighting CIMZIA,s long-...n,s disease patients presented at American College.../- Data from two studies,pr...f Gastroenterology,(ACG) Annual Meeting demonstrat...EGylated anti-TNF alpha (Tumor Necrosis Factor alp...
(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- A...today that a poster entitled "RDEA119, a Potent,an...in Dextran Sulfate,Sodium (DSS) -- induced Chronic...ollege of Gastroenterology (ACG) 2008 Annual Meeti... data from a preclinical study of,RDEA119, the Com...
Breaking Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4The story of Max Perutz a pioneering biologist with a remarkable passion for life 2832 1Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27 16388 1Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27 16388 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 1Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 2Obesity Costs U S Companies as Much as 2445 Billion a Year The Conference Board Reports 16384 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 1ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 2ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 3ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 4ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 5ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 6ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc 4499 7
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
Developed in conjunction with Pierce E. Scranton, Jr., M.D., the Seattle Small Joint Arthroscopy Set offers meticulously designed instrumentation for elbow, foot, and ankle surgeries.
The Smith & Nephew ECTRA II systems permit the surgeon to access and release the carpal tunnel ligament endoscopically, allowing access via two portals for distal and proximal cutting, while minimizi
The Stryker AZTEC Shoulder Holder is used for positioning the patients arm during surgery in the lateral position. The shoulder holder is adjustable with respect to height and rotation for all arm po
Medicine Products: